Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Details of updates to PTSC Business Overview Presentation

Thank you StormKing.

I really like the replacement of "300 on notice" with "hundreds" (something I've griped about for a long time after Leckrone said "485" over two years ago).

Being picky, I didn't like this:

After: Difficult to forecast future MMP license revenues, Limited institutional investor base….becoming an operating company can even out MMP revenue

Somebody please explain how becoming an operating company would have any influence on MMP revenue, i.e., MMP will be iratic regardless of how the "operating company" endeavors transpire, IMO.

SGE

Share
New Message
Please login to post a reply